X0708 D LIVE 0001782959 Capital Rx, Inc. 228 PARK AVENUE S. SUITE 87234 NEW YORK NY NEW YORK 10003 855-538-8897 DELAWARE Capital RX, LLC None Corporation true 2017 A. J. Loiacono 228 Park Avenue S. Suite 87234 New York NY NEW YORK 10003 Executive Officer Director Ryan Kelly 228 Park Avenue S. Suite 87234 New York NY NEW YORK 10003 Director Joseph Alexander 228 Park Avenue S. Suite 87234 New York NY NEW YORK 10003 Executive Officer Director Lenard Marcus 228 Park Avenue S. Suite 87234 New York NY NEW YORK 10003 Director Laura Alemzadeh 228 Park Avenue S. Suite 87234 New York NY NEW YORK 10003 Executive Officer Secretary Kevin Hill 4 Somerset Dr. Rumson NJ NEW JERSEY 07760 Director Jared Kesselheim c/o Transformation Capital, Attn: CFO 1 Federal Street, 25th Floor Boston MA MASSACHUSETTS 02110 Director Other Decline to Disclose 06b false 2020-12-21 false true false 0 52999994 31960628 21039366 Total offering amount consists of an initial closing of $31,960,627.84 and a milestone sale of $3,499,998.47 and up to an additional $17,539,367.40 at one or more subsequent closings with a right to purchase any remaining amount not sold. false 4 0 0 0 false Capital Rx, Inc. /s/ A.J. Loiacono A.J. Loiacono CEO 2021-01-05